Article Information
Published By
Online ISSN
History
- Received November 3, 2021
- Accepted March 1, 2022
- Published online March 17, 2022.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Theodore K. Marras1⇑,
- Mariam Hassan2,
- Kevin C. Mange2,
- Monika Ciesielska2,
- Shilpa Dhar Murthy2,
- Zhanna Jumadilova2 and
- Anjan Chatterjee2
- 1Department of Medicine, University of Toronto and Toronto Western Hospital, Toronto, ON, Canada
- 2Insmed Incorporated, Bridgewater, NJ, USA
- Corresponding author: Theodore K. Marras (ted.marras{at}uhn.ca)
Funding
Insmed Incorporated
Article usage
Altmetrics
Vol 8 Issue 2
Table of Contents
Amikacin Liposome Inhalation Suspension Clinical Benefit-Risk Assessment for Refractory MAC Lung Disease
